Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06222645

Comparison Between Fluorescence Imaging With Photoplethysmography (PPG) and Indocyanine Green (ICG) for Tissue Perfusion in Gastrointestinal Resections

Led by Saint Petersburg State University, Russia · Updated on 2025-11-18

200

Participants Needed

3

Research Sites

4 weeks

Total Duration

On this page

Sponsors

S

Saint Petersburg State University, Russia

Lead Sponsor

S

Shandong Linglong Yingcheng Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating two intraoperative imaging methods to assess tissue perfusion during gastrointestinal surgeries involving anastomoses. This randomized controlled trial compares a new non-contact optical technique called imaging photoplethysmography (iPPG) to the current standard, indocyanine green (ICG) fluorescence imaging. The aim is to determine how well the iPPG evaluations agree with both the visual and software-based analyses used in the ICG method, potentially refining perfusion assessment in clinical practice. Participants are randomly assigned to one of two groups. One group receives tissue perfusion assessment with the standard ICG fluorescence imaging, which requires an intravenous injection of the fluorescent dye ICG and involves both real-time visual interpretation by the surgeon and quantitative computer analysis of fluorescence data. The other group is assessed using the investigational iPPG system, which uses a conventional video camera to detect blood volume changes without any contrast agents, providing real-time perfusion maps to guide surgical decisions. During the study, participants undergo intraoperative perfusion evaluation based on their assigned method. Researchers measure outcomes including the incidence of anastomotic leaks within 30 days after surgery, comparing qualitative and quantitative assessments in the ICG group and benchmarking iPPG results against these. Additional outcomes include rates of anastomotic revision, postoperative complications, and re-interventions. The total follow-up period for measuring these outcomes is 30 days postoperatively, allowing for comprehensive evaluation of each imaging strategy's clinical utility.

CONDITIONS

Brief Title

PPG vs. ICG in Gastrointestinal Resections

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (age 65 18 years)
  • Scheduled for elective gastrointestinal resection needing a primary gastro-intestinal or entero-enteric anastomosis
  • Able to understand and provide written informed consent
Not Eligible

You will not qualify if you...

  • Known allergy or hypersensitivity to indocyanine green (ICG), iodine, or any component of the ICG formulation
  • Severe liver impairment (e.g., Child-Pugh Class C)
  • Pregnancy or breastfeeding
  • Emergency surgery
  • Unable to comply with the study protocol or follow-up schedule according to investigator's judgment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Day of surgery

Participants undergo gastrointestinal resection surgery with intraoperative tissue perfusion assessment using either the Indocyanine Green (ICG) fluorescence imaging or the Imaging Photoplethysmography (iPPG) system to guide surgical decisions.

1 visit (in-person, intraoperative)

Post-operative Follow-up

Duration - 30 days postoperatively

Participants are monitored for surgical outcomes, including assessment of anastomotic leak and other complications.

Approximately 2 to 3 visits during 30 days

Trial Site Locations

Total: 3 locations

1

Shandong Linglong Yingcheng Hospital

Yantai, Shandong, China, 265400

Actively Recruiting

2

High-Tech Clinic Beloostrov

Saint Petersburg, Leningradskaya Oblast', Russia, 197729

Active, Not Recruiting

3

Department of Faculty Surgery, Saint Petersburg State University

Saint Petersburg, Leningradskaya Oblast', Russia, 199034

Actively Recruiting

Loading map...

Research Team

X

Xuan - Qiu, MD

V

Victor A. Kashchenko, MD,PD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabe...

Metastatic Sarcoma

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here